Suppr超能文献

吲哚美辛口腔崩解儿科制剂的设计与评价优化研究

Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin.

作者信息

Singh Jashanjit, Philip Anil K, Pathak Kamla

机构信息

Department of Pharmaceutics, Rajiv Academy For Pharmacy, NH#2, Delhi- Mathura bypass, PO Chattikkara, Mathura, 281001 Uttar Pradesh, India.

出版信息

AAPS PharmSciTech. 2008;9(1):60-6. doi: 10.1208/s12249-007-9018-4. Epub 2008 Jan 9.

Abstract

In the present study, the aim was to optimize an orodispersible formulation of indomethacin using a combined approach of subliming agent and superdisintegrant. The tablets were made by non-aqueous wet granulation technique with superdisintegrant incorporated both intragranularly and extragranularly. A 2(3) factorial design was used to investigate the effects amount of subliming agents namely camphor and ammonium bicarbonate and taste masking and soothening hydrophilic agent mannitol as independent variables and disintegration time and crushing strength as dependent responses. The volatilization time of eight hours at 50 degrees C was optimized by conducting solid-state kinetic studies of optimized formulations. Optimized orodispersible tablets were evaluated for wetting time, water absorption ratio, porosity and in vitro and in vivo disintegration tests. Results show that higher levels of camphor and mannitol and a lower level of ammonium bicarbonate is desirable for orodispersion. Scanning electron microscopy (SEM) revealed the porous surface morphology and kinetic digital images substantiated the orodispersible property. Differential Scanning Calorimetry (DSC) studies exhibited physiochemical compatibility between indomethacin and various excipients used in the tablet formulation. Stability studies carried out as per ICH Q(1) A guidelines suggested the stable formulations for the tested time period of 6 months. The systematic approach of using subliming and disintegrating agents helped in achieving a stable, optimized orodispersible formulation, which could be industrially viable.

摘要

在本研究中,目的是采用升华剂和超级崩解剂相结合的方法优化吲哚美辛的口腔崩解制剂。片剂通过非水湿法制粒技术制备,超级崩解剂既包含在颗粒内也包含在颗粒外。采用2(3)析因设计来研究升华剂(即樟脑和碳酸氢铵)的用量以及掩味和舒缓亲水剂甘露醇作为自变量,崩解时间和抗压强度作为因变量的影响。通过对优化制剂进行固态动力学研究,优化了在50℃下8小时的挥发时间。对优化后的口腔崩解片进行了润湿时间、吸水率、孔隙率以及体外和体内崩解试验的评估。结果表明,较高水平的樟脑和甘露醇以及较低水平的碳酸氢铵有利于口腔崩解。扫描电子显微镜(SEM)显示了多孔表面形态,动力学数字图像证实了口腔崩解特性。差示扫描量热法(DSC)研究表明吲哚美辛与片剂配方中使用的各种辅料之间具有物理化学相容性。按照ICH Q(1)A指南进行的稳定性研究表明,在6个月的测试时间段内制剂稳定。使用升华剂和崩解剂的系统方法有助于实现一种稳定、优化的口腔崩解制剂,该制剂在工业上可行。

相似文献

1
Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin.
AAPS PharmSciTech. 2008;9(1):60-6. doi: 10.1208/s12249-007-9018-4. Epub 2008 Jan 9.
2
Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin.
AAPS PharmSciTech. 2008;9(1):87-94. doi: 10.1208/s12249-007-9026-4. Epub 2008 Jan 15.
3
Formulation and optimization of orodispersible tablets of diazepam.
AAPS PharmSciTech. 2010 Mar;11(1):356-61. doi: 10.1208/s12249-010-9387-y. Epub 2010 Mar 16.
5
Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method.
Indian J Pharm Sci. 2015 May-Jun;77(3):267-73. doi: 10.4103/0250-474x.159605.
6
Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
Eur J Pharm Biopharm. 2021 Nov;168:122-130. doi: 10.1016/j.ejpb.2021.08.016. Epub 2021 Aug 30.

引用本文的文献

1
Nanotechnological innovations in paediatric tuberculosis management: current trends and future prospects.
Front Drug Deliv. 2024 Jan 8;3:1295815. doi: 10.3389/fddev.2023.1295815. eCollection 2023.
10
Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
Adv Pharm Bull. 2017 Sep;7(3):399-408. doi: 10.15171/apb.2017.048. Epub 2017 Sep 25.

本文引用的文献

2
Fast dispersible ibuprofen tablets.
Eur J Pharm Sci. 2002 Apr;15(3):295-305. doi: 10.1016/s0928-0987(02)00011-8.
3
Evaluation of rapidly disintegrating tablets prepared by a direct compression method.
Drug Dev Ind Pharm. 1999 May;25(5):571-81. doi: 10.1081/ddc-100102211.
4
Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
Chem Pharm Bull (Tokyo). 1996 Nov;44(11):2121-7. doi: 10.1248/cpb.44.2121.
5
A new tablet disintegrating agent: cross-linked polyvinylpyrrolidone.
J Pharm Sci. 1973 Jan;62(1):43-9. doi: 10.1002/jps.2600620107.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验